Viewing Study NCT06628063



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06628063
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-29

Brief Title: Examination of Pregnant Women in Third Trimester by Ultrasound to Detect Any Congenital Anomalies
Sponsor: None
Organization: None

Study Overview

Official Title: Second and Third Trimestric Scan Versus Second Trimestric Scan Alone in Detection of Congenital Fetal Anomalies
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: this study aims to help the physicians to evaluate the practice of routine Third trimestric fetal scan whether it should be routinely performed to all cases including those with low risk singleton pregnancies
Detailed Description: The third-trimester ultrasound scan traditionally performed at 32-34weeks can assess fetal viability presentation anatomy growth amniotic fluid volume placental location and fetoplacental Doppler

There are multiple other indications that can trigger a third-trimester scan including antepartum bleeding reduced fetal movements preterm rupture of the membranes and suspected abnormalities of fetal growth based on physical examination In addition ultrasound may be used to guide other procedures in the third trimester such as external cephalic version However as yet there is no convincing evidence that routine universal third-trimester ultrasound examination in a low-risk population improves either perinatal or maternal outcome especially in low socioeconomic countries with limited resources

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None